Export financials
cbdMD (YCBD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

cbdMD Income Statement 2025-2011 | YCBD
Brief overview of revenue and earnings at cbdMD
This overview is based on financial performance over the past five years. cbdMD reported revenue of 41.9 million dollars in 2020 and 19.2 million dollars by 2025. The five-year change reached −54.2%, while CAGR stood at −14.5%. Revenue ended the period on a sustained downward trend.
Gross profit was 26.4 million dollars at the start and 12 million dollars at the end of the period (−54.6%). Revenue and direct costs changed at similar rates. Comparing the endpoints gives gross margins of 63% and 62.4%. Gross profitability remained broadly stable.
EBITDA was −$16.9 million at the beginning and −$1.8 million at the end of the period (+89.3%). Additional revenue translated efficiently into EBITDA. The EBITDA share of revenue changed from −40.3% to −9.4%. Higher profitability strengthens the quality of operating growth.
The final result was −9.4 million dollars initially and −2 million dollars in the final year. The direction improved, yet positive earnings are still absent.
What the figures show
Positive developments coexist with areas of weakness. The constructive conclusion rests on a stable gross margin, an improving EBITDA margin and improving net profitability. The weaker side of the profile includes a softer top-line trend and a low EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement cbdMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.58 M | 210 K | 1.4 M | 491 K | 54.9 M | 156 M | 65.5 M | 28.4 M | - | - | - | - | - | - | - |
Shares |
4.02 M | 539 K | 2.02 M | 1.33 M | 54.9 M | 52.1 M | 17.9 M | 7.74 M | - | - | - | - | - | - | - |
Historical Prices |
0.89 | 0.39 | 0.69 | 0.37 | 1.04 | 3.5 | 1.04 | 4.74 | 4.93 | - | - | - | - | - | - |
Net Income |
-2.04 M | -3.7 M | -997 K | -3.96 M | -19.2 M | -9.4 M | -50.4 M | -412 K | -1.74 M | -3.36 M | - | - | - | - | - |
Revenue |
19.2 M | 19.5 M | 24.2 M | 35.4 M | 44.5 M | 41.9 M | 23.7 M | 8.42 M | 4.47 M | 2.03 M | - | - | - | - | - |
Cost of Revenue |
7.22 M | 7.49 M | 9.18 M | 13.1 M | 14.5 M | 15.5 M | 9.14 M | 104 K | 1.36 M | 1.62 M | - | - | - | - | - |
Gross Profit |
12 M | 12 M | 15 M | 22.3 M | 30 M | 26.4 M | 14.5 M | 5.75 M | 3.12 M | 413 K | - | - | - | - | - |
Operating Income |
-2.16 M | -3.32 M | -22.5 M | -78.3 M | -19.6 M | -17.6 M | -14.8 M | -1.8 M | -1.36 M | -3.89 M | - | - | - | - | - |
Interest Expense |
34.3 K | -29.5 K | 63.7 K | 239 K | 29.5 K | 39.9 K | 75.1 K | 955 | 501 K | 155 K | - | - | - | - | - |
EBITDA |
-1.8 M | -2.86 M | -22.1 M | -77.3 M | -18.6 M | -16.9 M | -14.1 M | 340 K | -168 K | -3.69 M | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | 28.9 M | 5.63 M | 3.36 M | 4.15 M | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement cbdMD
| 2026-Q3 | 2026-Q2 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
5.78 M | 10.4 M | 9 M | 8.92 M | 5.78 M | 778 K | 569 K | 492 K | 449 K | 370 K | 2.96 M | 2.96 M | 2.38 M | 1.35 M | 1.34 M | 1.35 M | 1.32 M | 1.31 M | 57.8 M | 54.1 M | 56.7 M | 53.5 M | 52.1 M | 41.4 M | 51.3 M | 52.1 M | 27.7 M | 14.6 M | 23.2 M | 27.7 M | 10.1 M | 7.61 M | 8.08 M | 8.03 M | 6.91 M | 4.13 M | 4.69 M | 4.22 M | 3.49 M | 3.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.23 M | -798 K | -283 K | - | -895 K | -481 K | 15.1 K | - | 460 K | -3.01 M | -997 K | - | -1.77 M | -1.34 M | -3.96 M | -55.5 M | -31.6 M | -4.66 M | -19.2 M | -20.4 M | 1.54 M | -12.5 M | -9.4 M | -9.4 M | -9.4 M | -9.4 M | 12.9 M | -63.2 M | -29.2 M | 12.9 M | -2.19 M | 943 K | 565 K | -2.19 M | -1.26 M | -1.13 M | -142 K | -1.26 M | -697 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
4.61 M | 5.64 M | 5.02 M | - | 4.61 M | 4.75 M | 5.11 M | - | 5.17 M | 4.38 M | 5.38 M | - | 6.12 M | 6.24 M | 6.09 M | 27.5 M | 8.59 M | 9.63 M | 9.32 M | 34.7 M | 10.6 M | 11.8 M | 12.3 M | 30.2 M | 10.6 M | 12.3 M | 10.1 M | 14.1 M | 8.01 M | 10.1 M | 466 K | 6.97 M | 3.2 M | 3.03 M | 433 K | 3.4 M | 1.34 M | 1.14 M | 200 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.78 M | 2.38 M | 2.02 M | - | 1.78 M | 1.79 M | 1.71 M | - | 1.77 M | 1.8 M | 1.82 M | - | 2.27 M | 2.22 M | 2.52 M | 10.2 M | 2.66 M | 3.19 M | 4.33 M | 10.4 M | 3.37 M | 3.64 M | 3.43 M | 10.2 M | 3.75 M | 3.43 M | 3.7 M | 5.01 M | 2.93 M | 3.7 M | 165 K | 1.86 M | 1.11 M | 491 K | 228 K | 823 K | 261 K | 228 K | 163 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
2.83 M | 3.26 M | 3 M | - | 2.83 M | 2.96 M | 3.4 M | - | 3.4 M | 2.58 M | 3.56 M | - | 3.85 M | 4.02 M | 3.57 M | 17.4 M | 5.93 M | 6.44 M | 4.99 M | 24.2 M | 7.19 M | 8.16 M | 8.9 M | 20 M | 6.89 M | 8.9 M | 6.45 M | 9.1 M | 5.08 M | 6.45 M | 300 K | 5.11 M | 2.09 M | 758 K | 460 K | 2.57 M | 1.53 M | 460 K | 37.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-905 K | -801 K | -286 K | - | -905 K | -486 K | -86.3 K | - | -382 K | -1.55 M | -1.07 M | - | -1.82 M | -1.4 M | -4.05 M | -63.3 M | -33.1 M | -5.01 M | -25.1 M | -12.6 M | -6.68 M | -4.17 M | -1.76 M | -13.1 M | -1.34 M | -1.76 M | -6.11 M | -9.59 M | -6.47 M | -6.11 M | -1.09 M | 949 K | 627 K | -2.32 M | -1.3 M | -1.09 M | -179 K | -1.3 M | -695 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
9.41 K | 2.81 K | 3.16 K | - | 9.41 K | 7.64 K | 11.4 K | - | -12.7 K | -18.4 K | -418 | - | 9.72 K | 17.8 K | 29.1 K | 137 K | 64.4 K | 2.25 K | 70.7 K | - | -2.58 K | -10.6 K | -10.4 K | 46.3 K | 3.44 K | -10.4 K | 7.27 K | 50.2 K | -14.2 K | -18.1 K | -44 K | 737 | 232 | -44 K | 259 | 500 K | 229 K | -259 | -132 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-816 K | -756 K | -232 K | - | -713 K | -295 K | 20.5 K | - | -209 K | -1.38 M | -955 K | - | - | - | -3.95 M | -62.5 M | -33 M | -4.69 M | -24.8 M | -11.9 M | -6.43 M | -3.93 M | -1.53 M | -12.6 M | -1.05 M | -1.53 M | -6 M | -9.31 M | -6.3 M | -6 M | -1.03 M | 1.12 M | 744 K | -2.26 M | -1.24 M | -1.04 M | -151 K | -1.24 M | -686 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.5 M | 12 M | - | 13.9 M | 12.3 M | 10.7 M | 33.1 M | 8.23 M | 10.7 M | 12.6 M | 18.7 M | 11.5 M | 12.6 M | 1.39 M | 4.09 M | 1.46 M | 1.54 M | 1.69 M | 2.54 M | 854 K | 1.69 M | 600 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company cbdMD (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.